Literature DB >> 25116623

Platelet-derived growth factor mediates interleukin-13-induced collagen I production in mouse airway fibroblasts.

Jiamei Lu1, Yanting Zhu, Wei Feng, Yilin Pan, Shaojun Li, Dong Han, Lu Liu, Xinming Xie, Guizuo Wang, Manxiang Li.   

Abstract

Interleukin-13 (IL-13) is associated with the production of collagen in airway remodelling of asthma. Yet, the molecular mechanisms underlying IL-13 induction of collagen remain unclear; the aim of this study is to address this issue. IL-13 dose- and time-dependently-induced collagen I production in primary cultured airway fibroblasts; this was accompanied with the STAT6 phosphorylation, and pre-treatment of cells with JAK inhibitor suppressed IL-13- induced collagen I production. Further study indicated that IL-13 stimulated JAK/STAT6-dependent PDGF production and subsequent ERK1/2 MAPK activation in airway fibroblasts, and the presence of either PDGF receptor blocker or MEK inhibitor partially suppressed IL-13-induced collagen I production. Taken together, our study suggests that activation of JAK/STAT6 signal pathway and subsequent PDGF generation and resultant ERK1/2 MAPK activation mediated IL-13-induced collagen I production in airway fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25116623     DOI: 10.1007/s12038-014-9454-8

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  23 in total

Review 1.  Regulation of PDGF and its receptors in fibrotic diseases.

Authors:  James C Bonner
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

Review 2.  Airway remodeling in asthma.

Authors:  Rabih Halwani; Saleh Al-Muhsen; Qutayba Hamid
Journal:  Curr Opin Pharmacol       Date:  2010-06-28       Impact factor: 5.547

3.  Activation of STAT6 by STING is critical for antiviral innate immunity.

Authors:  Huihui Chen; Hui Sun; Fuping You; Wenxiang Sun; Xiang Zhou; Lu Chen; Jing Yang; Yutao Wang; Hong Tang; Yukun Guan; Weiwei Xia; Jun Gu; Hiroki Ishikawa; Delia Gutman; Glen Barber; Zhihai Qin; Zhengfan Jiang
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

4.  Lebrikizumab treatment in adults with asthma.

Authors:  Jonathan Corren; Robert F Lemanske; Nicola A Hanania; Phillip E Korenblat; Merdad V Parsey; Joseph R Arron; Jeffrey M Harris; Heleen Scheerens; Lawren C Wu; Zheng Su; Sofia Mosesova; Mark D Eisner; Sean P Bohen; John G Matthews
Journal:  N Engl J Med       Date:  2011-08-03       Impact factor: 91.245

5.  Interleukin-13 peptide kinoid vaccination attenuates allergic inflammation in a mouse model of asthma.

Authors:  Qiuping Jing; Tao Yin; Yang Wan; Huashan Shi; Shuntao Luo; Meng Li; Hailong Zhang; Hong He; Shijia Liu; Haoyu Li; Yuquan Wei; Li Yang
Journal:  Int J Mol Med       Date:  2012-06-19       Impact factor: 4.101

6.  Vaccination with platelet-derived growth factor B kinoids inhibits CCl₄-induced hepatic fibrosis in mice.

Authors:  Zhi-Ming Hao; Xiao-Bao Fan; Shuang Li; Yi-Fei Lv; Hou-Qiang Su; Hui-Ping Jiang; Hong-Hong Li
Journal:  J Pharmacol Exp Ther       Date:  2012-06-18       Impact factor: 4.030

7.  Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.

Authors:  Gaoyun Yang; Amy Volk; Ted Petley; Eva Emmell; Jill Giles-Komar; Xiaozhou Shang; Jian Li; Anuk M Das; Dave Shealy; Don E Griswold; Li Li
Journal:  Cytokine       Date:  2004-12-21       Impact factor: 3.861

8.  Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytes.

Authors:  Pavel Krejci; Jirina Prochazkova; Vitezslav Bryja; Petra Jelinkova; Katerina Pejchalova; Alois Kozubik; Leslie Michels Thompson; William R Wilcox
Journal:  Cell Signal       Date:  2008-10-12       Impact factor: 4.315

9.  Interleukin-4 and interleukin-13 enhance human bronchial smooth muscle cell proliferation.

Authors:  Ynuk Bossé; Charles Thompson; Karine Audette; Jana Stankova; Marek Rola-Pleszczynski
Journal:  Int Arch Allergy Immunol       Date:  2008-01-18       Impact factor: 2.749

10.  Sustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in mice.

Authors:  Yanbing Ma; Andrew J Halayko; Sujata Basu; Qingdong Guan; Carolyn R Weiss; Allan G Ma; Kent T HayGlass; Allan B Becker; Richard J Warrington; Zhikang Peng
Journal:  Am J Respir Cell Mol Biol       Date:  2013-05       Impact factor: 6.914

View more
  5 in total

Review 1.  Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.

Authors:  Xiao-Lei Huang; Yu-Jie Wang; Jun-Wei Yan; Ya-Nan Wan; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflamm Res       Date:  2015-03-01       Impact factor: 4.575

2.  The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma.

Authors:  A L da Silva; R F Magalhães; V C Branco; J D Silva; F F Cruz; P S Marques; T P T Ferreira; M M Morales; M A Martins; P C Olsen; P R M Rocco
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

3.  Complex association patterns for inflammatory mediators in induced sputum from subjects with asthma.

Authors:  A T Hastie; C Steele; C W Dunaway; W C Moore; B M Rector; E Ampleford; H Li; L C Denlinger; N Jarjour; D A Meyers; E R Bleecker
Journal:  Clin Exp Allergy       Date:  2018-04-15       Impact factor: 5.018

4.  IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury.

Authors:  Megan N Ballinger; Michael W Newstead; Xianying Zeng; Urvashi Bhan; Xiaokui M Mo; Steven L Kunkel; Bethany B Moore; Richard Flavell; John W Christman; Theodore J Standiford
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

5.  SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-β1 signaling.

Authors:  Ching-Ying Wang; Chien-Yi Lu; Shih-Wen Li; Chien-Chen Lai; Chun-Hung Hua; Su-Hua Huang; Ying-Ju Lin; Mann-Jen Hour; Cheng-Wen Lin
Journal:  Virus Res       Date:  2017-04-13       Impact factor: 3.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.